SBC Medical Group Holdings Inc (SBC) FinancialsSBCFinancialSBC Medical Group Holdings Inc

SBC Medical Group Holdings Inc (SBC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Procurement services, accounting for 27.2% of total sales, equivalent to $13.40M. Other significant revenue streams include Management services and Franchising revenue. Understanding this composition is critical for investors evaluating how SBC navigates market cycles within the Business Support Services industry.

Evaluating the bottom line, SBC Medical Group Holdings Inc maintains a gross margin of 73.14%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 38.55%, while the net margin is 22.69%. These profitability ratios, combined with a Return on Equity (ROE) of 19.29%, provide a clear picture of how effectively SBC converts its operational activities into shareholder value.

In the context of the broader market, SBC competes directly with industry leaders such as ACTG and IMXI. With a market capitalization of $416.53M, it holds a significant position in the sector. When comparing efficiency, SBC's gross margin of 73.14% stands against ACTG's 49.81% and IMXI's 100.00%. Such benchmarking helps identify whether SBC Medical Group Holdings Inc is trading at a premium or discount relative to its financial performance.

SBC Medical Group has shown strong financial performance with a gross margin of 73.14% in Q2 2026, indicating efficient cost management. The company also reported a net income of $10.69 million for the same quarter, reflecting solid profitability despite market challenges.